Corrections: Distribution of hepatitis B virus genotypes in Korea.
The Korean Journal of Hepatology.2009;15(3):424-424. doi:10.3350/kjhep.2009.15.3.424
No abstract available.
The Korean Journal of Hepatology
1995 to Present ISSN: 1226-0479
Sort by
DISPLAY OPTIONS
Format:
Per page:
The Korean Journal of Hepatology.2009;15(3):383-390. doi:10.3350/kjhep.2009.15.3.383
No abstract available.
The Korean Journal of Hepatology.2009;15(3):379-382. doi:10.3350/kjhep.2009.15.3.379
No abstract available.
Contrast Media/diagnostic use ; Female ; Hepatic Veins/ultrasonography ; Humans ; Middle Aged ; Peliosis Hepatis/*diagnosis/ultrasonography ; Tomography, X-Ray Computed
Contrast Media/diagnostic use ; Female ; Hepatic Veins/ultrasonography ; Humans ; Middle Aged ; Peliosis Hepatis/*diagnosis/ultrasonography ; Tomography, X-Ray Computed
Large liver cell change/dysplasia in hepatitis B virus-related liver cirrhosis.
The Korean Journal of Hepatology.2009;15(3):375-378. doi:10.3350/kjhep.2009.15.3.375
No abstract available.
Biopsy, Fine-Needle ; Hepatitis B virus ; Hepatitis B, Chronic/*complications ; Hepatocytes/*pathology ; Humans ; Liver Cirrhosis/diagnosis/*pathology/virology ; Risk Factors
Biopsy, Fine-Needle ; Hepatitis B virus ; Hepatitis B, Chronic/*complications ; Hepatocytes/*pathology ; Humans ; Liver Cirrhosis/diagnosis/*pathology/virology ; Risk Factors
The Korean Journal of Hepatology.2009;15(3):370-374. doi:10.3350/kjhep.2009.15.3.370
Combination therapy of pegylated interferon alpha and ribavirin has been associated with various adverse effects, but sudden-onset hearing loss is uncommon. We report a 60-year-old male patient who developed sudden-onset hearing loss during combination therapy with pegylated interferon alpha and ribavirin for chronic hepatitis C. This patient had been diagnosed with chronic hepatitis C (genotype Ib) and early-stage liver cirrhosis 3 years previously, and had been treated with conventional interferon-alpha and ribavirin for 12 months. However, 6 months from the end of the treatment course the patient relapsed and received combination retreatment with pegylated interferon alpha-2b and ribavirin. He developed sudden-onset right-side hearing loss and tinnitus 42 weeks after the start of this retreatment. Pure-tone audiometry revealed a right-side hearing loss of 60~90dB. The patient consequently immediately discontinued the pegylated interferon therapy and was given prednisone 60 mg/day for 10 days, after which the hearing loss had almost completely recovered.
Anti-Inflammatory Agents/therapeutic use ; Antiviral Agents/*adverse effects/therapeutic use ; Audiometry, Pure-Tone ; Drug Therapy, Combination ; Hearing Loss, Sudden/chemically induced/*diagnosis ; Hepatitis C, Chronic/diagnosis/*drug therapy ; Humans ; Interferon Alfa-2b/*adverse effects/therapeutic use ; Liver Cirrhosis/diagnosis ; Male ; Middle Aged ; Polyethylene Glycols/*adverse effects/therapeutic use ; Prednisone/therapeutic use ; Ribavirin/*adverse effects/therapeutic use
Anti-Inflammatory Agents/therapeutic use ; Antiviral Agents/*adverse effects/therapeutic use ; Audiometry, Pure-Tone ; Drug Therapy, Combination ; Hearing Loss, Sudden/chemically induced/*diagnosis ; Hepatitis C, Chronic/diagnosis/*drug therapy ; Humans ; Interferon Alfa-2b/*adverse effects/therapeutic use ; Liver Cirrhosis/diagnosis ; Male ; Middle Aged ; Polyethylene Glycols/*adverse effects/therapeutic use ; Prednisone/therapeutic use ; Ribavirin/*adverse effects/therapeutic use
The Korean Journal of Hepatology.2009;15(3):362-369. doi:10.3350/kjhep.2009.15.3.362
Hepatitis A is generally known as a mild, self-limiting disease of the liver, but in rare instances it can progress to fulminant hepatitis, which may require liver transplantation for recovery. Such cases are known to be related to old age and underlying liver disease. We report four cases of hepatitis A in which patients presented with fulminant hepatitis and acute renal failure and underwent liver transplantation. The following common features were observed in our cases: (1) occurrence in relatively old age (> or =39 years old), (2) association with acute renal failure, (3) presence of hepatomegaly, and (4) microscopic features of submassive hepatic necrosis.
Adult ; Age Factors ; Female ; Hepatitis/complications/*diagnosis/therapy ; Hepatitis A/complications/*diagnosis ; Hepatomegaly/diagnosis/etiology ; Humans ; Kidney Failure, Acute/complications/*diagnosis ; Liver/pathology ; Liver Cirrhosis/diagnosis/etiology ; *Liver Transplantation ; Male ; Tomography, X-Ray Computed
Adult ; Age Factors ; Female ; Hepatitis/complications/*diagnosis/therapy ; Hepatitis A/complications/*diagnosis ; Hepatomegaly/diagnosis/etiology ; Humans ; Kidney Failure, Acute/complications/*diagnosis ; Liver/pathology ; Liver Cirrhosis/diagnosis/etiology ; *Liver Transplantation ; Male ; Tomography, X-Ray Computed
The Korean Journal of Hepatology.2009;15(3):357-361. doi:10.3350/kjhep.2009.15.3.357
Bone is a common site of metastasis in patients with hepatocellular carcinoma (HCC). We report a rare case of rib metastasis from HCC treated by transcatheter arterial chemoembolization (TACE). A 55-year-old man with liver cirrhosis presented with right lower chest pain. The diagnosis was an HCC with a bone metastasis in the right eighth rib. Intra-arterial injections of doxorubicin mixed with Lipiodol and Gelfoam particles were instituted through the right eighth intercostal artery. Computed tomography and a Tc99-labeled scan performed 2 months after the third TACE revealed no viable HCC in the right eighth rib.
Bone Neoplasms/radiography/secondary/*therapy ; Carcinoma, Hepatocellular/diagnosis/secondary/*therapy ; *Chemoembolization, Therapeutic ; Doxorubicin/administration & dosage ; Gelatin Sponge, Absorbable/administration & dosage ; Hepatic Artery/pathology ; Humans ; Injections, Intra-Arterial ; Iodized Oil/administration & dosage ; Liver Cirrhosis/diagnosis/pathology ; Liver Neoplasms/diagnosis/pathology/*therapy ; Male ; Middle Aged ; *Ribs/radiography/radionuclide imaging ; Tomography, X-Ray Computed
Bone Neoplasms/radiography/secondary/*therapy ; Carcinoma, Hepatocellular/diagnosis/secondary/*therapy ; *Chemoembolization, Therapeutic ; Doxorubicin/administration & dosage ; Gelatin Sponge, Absorbable/administration & dosage ; Hepatic Artery/pathology ; Humans ; Injections, Intra-Arterial ; Iodized Oil/administration & dosage ; Liver Cirrhosis/diagnosis/pathology ; Liver Neoplasms/diagnosis/pathology/*therapy ; Male ; Middle Aged ; *Ribs/radiography/radionuclide imaging ; Tomography, X-Ray Computed
Apoptosis and diagnosis of nonalcoholic steatohepatitis.
The Korean Journal of Hepatology.2011;17(3):247-249. doi:10.3350/kjhep.2011.17.3.247
No abstract available.
Sclerosing hemangioma in the liver.
The Korean Journal of Hepatology.2011;17(3):242-246. doi:10.3350/kjhep.2011.17.3.242
Early hepatocellular carcinoma.
The Korean Journal of Hepatology.2011;17(3):238-241. doi:10.3350/kjhep.2011.17.3.238
No abstract available.
Carcinoma, Hepatocellular/*pathology ; Humans ; Immunohistochemistry ; Keratin-7/metabolism ; Liver Neoplasms/*pathology ; Magnetic Resonance Imaging ; Male ; Middle Aged
Carcinoma, Hepatocellular/*pathology ; Humans ; Immunohistochemistry ; Keratin-7/metabolism ; Liver Neoplasms/*pathology ; Magnetic Resonance Imaging ; Male ; Middle Aged
Country
Republic of Korea
Publisher
Korean Association for the Study of the Liver
ElectronicLinks
http://e-cmh.org/Editor-in-chief
Jin Wook Kim
kasl@kams.or.kr
Abbreviation
Korean J Hepatol
Vernacular Journal Title
대한간학회지
ISSN
1226-0479
EISSN
Year Approved
2007
Current Indexing Status
Currently Indexed
Start Year
1995
Description
Clinical and Molecular Hepatology(CMH), an official journal of The Korean Association for the Study of the Liver, is issued quarterly and published in English. The aim of the journal is to provide a forum for medical doctors and basic scientists working in the field of hepatology.
Powered by IMICAMS(
备案号: 11010502037788, 京ICP备10218182号-8)